RFP - Supply of selective Cyclooxygenase-2 (COX-2) inhibitors
PHARMAC invites proposals for the supply of selective cyclooxygenase-2 (COX-2) inhibitors in New Zealand; specifically, celecoxib and etoricoxib.
This request for proposals (RFP) letter incorporates the following schedules:
- Schedule 1 specifies the pharmaceuticals for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
- Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
- Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
- Schedule 4 contains the RFP form in which you are to provide details of your proposal.
Full text of RFP - supply of selective cyclooxygenase-2 (COX-2) inhibitors [PDF, 207 KB]
If you have any questions about this RFP, please post these on GETS or alternatively contact Chloë Dimock by email at email@example.com at PHARMAC.
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) - reference number 17743670 - no later than 5.00 p.m. on 26 August 2016.
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested suppliers to register with GETS and subscribe to this RFP to be kept up to date.